Cost‐benefit analysis of non‐pharmacological treatment of hypertension
- 1 October 1991
- journal article
- clinical trial
- Published by Wiley in Journal of Internal Medicine
- Vol. 230 (4) , 307-312
- https://doi.org/10.1111/j.1365-2796.1991.tb00449.x
Abstract
In this study a non‐pharmacological treatment (NPT) programme and conventional drug treatment of hypertension was compared in a cost‐benefit analysis. The NPT programme involved 400 patients and was conducted at 8 health centres during the period 1984–1986. It consisted of monthly visits by a nurse, visits by a doctor every 6 months, home blood pressure (BP) measurements, dietary advice, relaxation, physical activity, etc. The patients were also followed up for 2 years after the study to assess whether the programme still worked, and whether future treatment costs were affected. The treatment costs were about SEK 5300 higher per patient for the NPT programme. The benefits, in the form of reduced treatment costs for the period 1986–1988 and willingness to pay (WTP) for the NPT programme, were about SEK 3200. Thus the NPT programme resulted in a loss of about SEK 2100 per patient. However, a longer follow‐up period is needed for any specific conclusions to be drawn about the costs and benefits of the NPT programme, as compared with conventional drug treatment.Keywords
This publication has 6 references indexed in Scilit:
- The costs of treating hypertension — an analysis of different cut-off pointsHealth Policy, 1991
- Economic evaluation in health care: Is there a role for cost-benefit analysis?Health Policy, 1991
- The Costs of Treating Hypertension in SwedenScandinavian Journal of Primary Health Care, 1991
- Addition of non‐pharmacological methods of treatment in patients on antihypertensive drugs: results of previous medication, laboratory tests and life qualityJournal of Internal Medicine, 1989
- The demand for health: theory and applications.Journal of Epidemiology and Community Health, 1986
- Seven CountriesPublished by Harvard University Press ,1980